Related Experiment Video
Updated: Apr 25, 2026
Implantation of the Syncardia Total Artificial Heart
Published on: July 17, 2014
[Heart transplantation 1981. A status determination]
Insights
Stanford University
Area of Science:
- Cardiovascular Surgery
- Cardiac Transplantation
- Heart Failure Management
Context:
- Report details Stanford University's experience with heart transplantation.
- Focuses on patient selection and outcomes.
Purpose:
- To outline the indications and contraindications for heart transplantation.
- To report on the long-term survival rates achieved at Stanford.
Summary:
- Heart transplantation is indicated for end-stage cardiomyopathy and coronary heart disease.
- Contraindications include advanced age, pulmonary hypertension, infections, and diabetes.
- Postoperative care is critical for favorable long-term results, with a 55% survival rate for patients post-1973.
Impact:
- Provides critical data on heart transplant viability and patient selection criteria.
- Highlights the importance of comprehensive postoperative care in achieving successful outcomes.
- Offers a benchmark for comparing heart transplant success rates with other organ transplants.
Abstract:
This is a report based on the experience of Stanford University in Palo Alto/California (Chief: N. Shumway). The operation is above all indicated in patients suffering from endstage cardiomyopathy respectively coronary heart disease. Stage IV valve patients (according to N. Y. H. A.) represent no candidates at the present time. Main contraindications are age over 50 years, pulmonary hypertension (above 8--10 resistance units), florid infections and diabetes mellitus. Perfect postoperative care is the key for success at Stanford; only that way long-term results compare favourably to those of kidney transplants: for the patient group after 1973 long-term survival rate is 55 percent.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
01:28Kidney Transplant I: Introduction